BYD Company Limited
002594
LONGi Green Energy Technology
601012
Contemporary Amperex Technology
300750
4
China Galaxy
601881
5
Ping An Insurance
601318
CN Stock MarketDetailed Quotes
002004 Huapont Life Sciences
- 3.90
- -0.01-0.26%
Trading Feb 27 09:58 CST
7.72BMarket Cap30.95P/E (TTM)
3.93High3.89Low54.71KlotVolume3.91Open3.91Pre Close21.36MTurnover0.29%Turnover Ratio25.49P/E (Static)1.98BShares5.2352wk High0.76P/B7.34BFloat Cap3.6852wk Low4.30Limit Up1.88BShs Float18.17Historical High3.52Limit Down1.02%Amplitude-1.63Historical Low0.22Dividend TTM3.90Avg Price23.03KlotAsk5.64%Div YieldTTM100Lot Size31.56KlotBid
Huapont Life Sciences News
Huabang Health: 2024 Annual Results Forecast
Huabang Health: Announcement on the extension of the controlling shareholder\'s partial share pledge
Huabang Health: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Huabang Health: Legal Opinion of the 2024 First Extraordinary General Meeting of Shareholders
Huabang Health: Comparative table of amendments to the company\'s articles of association
Huabang Health: Announcement of Resolutions of the 14th Meeting of the Eighth Board of Supervisors
Huabang Health: Feasibility analysis report on the development of forward foreign exchange settlement services and RMB to foreign exchange option portfolios in 2025
Huabang Health: Supervisory Board Rules of Procedure (December 2024)
Huabang Health: Announcement on the expected launch of forward foreign exchange settlement services and RMB to foreign exchange option combinations in 2025
Huabang Health: Shareholders\' Meeting Rules of Procedure (December 2024)
Huabang Health: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Huabang Health: Administrative Measures on the Use of Funds Raised (December 2024)
Huabang Health: Announcement on the Company and its subsidiaries applying for credit lines and guarantee matters from banks and other financial institutions in 2025
Huabang Health: Announcement of Resolutions of the 21st Meeting of the Eighth Board of Directors
Huabang Health: Board of Directors Rules of Procedure (December 2024)
Huabang Health: Articles of Association (December 2024)
Huabang Health: Independent opinions of independent directors on matters related to the 21st meeting of the 8th board of directors
Huabang Health: Announcement on increasing the forecast for daily related transactions in 2024 and the expected daily related transactions for 2025
Huabang Health: Announcement on the non-public issuance of exchangeable corporate bonds
Huabang Health: Announcement on the Wholly-owned Subsidiary Obtaining the “Drug Registration Certificate”